Search for Clinical Trial Results
Dendritic Cell Tumor - 14 Studies Found
Status | Study |
Recruiting |
Study Name: Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD Condition:
|
Completed |
Study Name: MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia Condition:
Interventions: |
Active, not recruiting |
Study Name: Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies Condition:
|
Active, not recruiting |
Study Name: An Open-label Phase II Study of Lorvotuzumab Mertansine Condition: Leukemia Date: 2015-04-15 Interventions: Drug: Lorvotuzumab Mertansine (IMGN901) 100 mg/m2 by vein on Day 1 and 8 of a 21-day cycle. |